Jefferies Financial Group’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.29M Sell
2,303
-17,769
-89% -$11.4M 0.01% 820
2025
Q4
$13.6M Sell
20,072
-393
-2% -$268K 0.07% 263
2025
Q3
$13.1M Sell
20,465
-1,173
-5% -$712K 0.06% 193
2025
Q2
$11.6M Buy
21,638
+2,099
+11% +$1M 0.1% 144
2025
Q1
$8.21M Sell
19,539
-7,067
-27% -$3.07M 0.07% 188
2024
Q4
$11M Buy
26,606
+14,711
+124% +$6.45M 0.07% 208
2024
Q3
$6.01M Buy
11,895
+635
+6% +$308K 0.04% 272
2024
Q2
$5.49M Sell
11,260
-1,880
-14% -$944K 0.06% 267
2024
Q1
$7.09M Sell
13,140
-6,793
-34% -$3.71M 0.07% 220
2023
Q4
$11.1M Buy
19,933
+16,915
+560% +$7.94M 0.07% 203
2023
Q3
$1.32M Buy
3,018
+1,381
+84% +$689K 0.01% 743
2023
Q2
$822K Sell
1,637
-4,201
-72% -$2.01M 0.01% 1001
2023
Q1
$2.92M Buy
5,838
+138
+2% +$66K 0.02% 535
2022
Q4
$2.33M Buy
+5,700
New +$2.21M 0.02% 605

Other funds holding IDXX

Jefferies Financial Group's IDXX Position: Q1 2026 in Review

Jefferies Financial Group reduced its Idexx Laboratories (IDXX) stake by 89% in Q1 2026, selling an estimated $11.4M and leaving 2,303 shares worth $1.29M. The position accounts for 0.01% of the portfolio, ranked #820.

Jefferies Financial Group first reported a position in IDXX in Q4 2022 and has held it in 14 quarters since. The position peaked at $13.6M in Q4 2025. 1,311 funds tracked by Wall St. Rank hold IDXX as of Q1 2026.

  • Jefferies Financial Group held 2,303 shares of Idexx Laboratories worth $1.29M as of Q1 2026.
  • Jefferies Financial Group sold 17,769 Idexx Laboratories shares in Q1 2026, an estimated $11.4M.
  • Idexx Laboratories made up 0.01% of Jefferies Financial Group's portfolio in Q1 2026, its #820 holding.
  • Jefferies Financial Group first reported a position in Idexx Laboratories in Q4 2022 and has held it in 14 quarters since.
  • Jefferies Financial Group's Idexx Laboratories position peaked at $13.6M in Q4 2025.
  • 1,311 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2026.

Based on Jefferies Financial Group's 13F filing for Q1 2026, filed 8 May 2026.